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The Gender Congruence and Life Satisfaction Scale (GCLS): Development and 
Validation of a Scale to Measure Outcomes from Transgender Health Services  
Abstract 
Background: It is vital that the treatment offered at transgender health services can be 
evaluated to ensure a high quality of care. However, the tools currently used to evaluate 
treatment at transgender health services are limited by mainly focusing on mental health or 
because they have been developed for binary transgender people only. This study therefore 
aimed to develop and validate a tool that addresses these limitations. The Gender Congruence 
and Life Satisfaction Scale (GCLS) was developed through reviewing the literature, 
conducting interviews with transgender people, and holding discussions with experts working 
in transgender healthcare. An initial pool of items was developed and feedback on these was 
obtained. The tool was then validated. 
Method: For the validation of the tool a total of 789 participants (451 transgender [171 
transgender females, 147 transgender males, 133 non-binary identifying people], and 338 
cisgender [254 females, 84 males]) were recruited from the United Kingdom to test the factor 
structure and validity of the GCLS.  
Results: Exploratory factor analysis retained 38 items which formed seven subscales 
(psychological functioning; genitalia; social gender role recognition; physical and emotional 
intimacy; chest; other secondary sex characteristics; and life satisfaction). These seven 
subscales were found to have good internal consistency and convergent validity. The GCLS 
was also found to be capable of discriminating between groups (e.g., people who have and 
have not undergone gender affirming medical interventions). Transgender and cisgender 
subscale norms are provided for the GCLS.  
Conclusion: The GCLS is a suitable tool to use with the transgender population to measure 
health-related outcomes for both clinical and research purposes.  
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Introduction 
Transgender people are those who experience a discrepancy between the gender they were 
assigned at birth and their gender identity. Transgender males are people who were assigned 
female at birth, on the basis of their sexual characteristics, but identify as male. Transgender 
females are people who were assigned male at birth, on the basis of their sexual 
characteristics, but identity as female. Some transgender people may also identify between or 
outside the binary gender spectrum. These people may choose to identify as gender neutral 
(feeling that one is neither male nor female), non-gender (having no gender in relation to 
presentation), or gender queer (identifying and presenting in a way that is outside the gender 
dichotomy of male and female) (Arcelus & Bouman, 2017; Richards, Bouman, & Barker, 
2017, Richards et al., 2016). Some people may also be more fluid with their gender identity 
whereby they do not have a fixed gender and it can therefore vary over time. Cisgender 
people do not experience such discrepancy (Arcelus & Bouman, 2017; Bouman et al., 2017). 
Many transgender people experience high levels of distress due to the discrepancy between 
their birth-assigned gender and gender identity (e.g., Beek, Kreukels, Cohen-Kettenis, & 
Steensma, 2015). To alleviate this distress, many transgender people will approach 
transgender health services in order to access gender affirming medical interventions (GAMI) 
to help them transition to the gender they identify with. Health professionals working at 
transgender health services may start their patients on cross-sex hormone treatment to induce 
either masculinization (with testosterone) or feminization (with estrogen and often with 
testosterone-blocking medication), depending on the patient’s gender identity (Coleman et 
al., 2012; Wylie et al., 2014). After living as their experienced gender, transgender people, if 
they wish to do so, can be referred for gender affirming surgery (Coleman et al., 2012; Wylie 
et al., 2014).  
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Transgender health services throughout Europe and North America have seen a substantial 
increase in the number of referrals in recent years. This has put a strain on these services, 
especially in relation to waiting times for assessment and treatment (Aitken et al., 2015; de 
Vries, Kreukels, T’Sjoen, Ålgars, & Mattila, 2015). In the United Kingdom (UK) patients can 
expect to wait more than one year before their first appointment at a transgender health 
service (Bouman & Richards, 2013; UK Trans Info, 2016). In light of this, evaluating the 
care and treatment received at these services is important. This will allow for the quality of 
care to be improved and will also facilitate the identification of service and personal factors 
associated with positive and negative outcomes (e.g., Dawson, Doll, Fitzpatrick, Jenkinson, 
& Carr, 2010). If factors associated with positive and negative outcomes of transgender 
health services can be identified, patient-centered services can be created which provide extra 
support for patients who are vulnerable to poorer outcomes. Identification of these factors 
may also help to make the treatment process timely and more efficient for patients who are 
deemed not to be vulnerable. Patient-centered services are crucial in improving patient 
outcomes (e.g., Lauver et al., 2002). In addition, within nationalized social healthcare 
systems which are present in most European countries, access to care, including transgender 
healthcare is free at the point of access for all citizens. However, these healthcare systems 
have limited resources and, at some point, rationing decisions may have to be made. Tools 
that predict which interventions are associated with good outcomes are vital to assist with 
making decisions regarding the allocation of healthcare resources and to explore how to 
improve overall patient outcomes. 
 
Research has explored patient treatment outcomes post-gender affirming interventions, such 
as cross-sex hormones and gender affirming genital surgery. On the whole, these studies have 
demonstrated that mental health and quality of life improve following gender affirming 
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medical interventions (e.g., Dhejne, Van Vlerken, Heylens, & Arcelus, 2016; Jones, Haycraft, 
Murjan, & Arcelus, 2016; Marshall, Claes, Bouman, Witcomb, & Arcelus, 2015; Murad et 
al., 2010; Van de Grift et al., 2018; Witcomb et al., 2018). The main focus of outcome 
evaluations at transgender health services has often been based around mental health 
symptoms (e.g., anxiety, depression) (e.g., Bouman et al., 2016, 2017; Heylens et al., 2014; 
Murad et al., 2010; Witcomb et al., 2018). While mental health is evidently an important 
aspect to include within any outcome assessment of gender affirming medical interventions, 
given the high prevalence of mental health problems transgender people often experience pre-
gender affirming medical interventions (Dhejne et al., 2016), it should not be the sole focus. 
Researchers have argued that improvements in mental health should not be the only focus of 
transgender health service evaluations, as mental health interventions are generally not 
provided by transgender health services (Arcelus & Bouman, 2015; Dhejne et al., 2016). 
Patient outcomes will also be biased by levels of mental health problems experienced pre-
treatment. Moreover, the treatment pathways for transgender people consist of 
multidisciplinary treatment options, which further complicates the evaluation of these 
interventions.  
 
One of the most important outcomes that should be measured after gender affirming medical 
interventions is a change in the distress and unhappiness a person experiences with their 
experienced gender and body as a result of their gender identity being at odds with their 
assigned gender (i.e., gender incongruence). Measurement of this outcome is often neglected 
due to the lack of available measures that have been developed with the transgender 
population and are capable of assessing a change in distress and unhappiness a person 
experiences with their gender and body. The few measures that are available to assess gender 
distress (such as the Utrecht Gender Dysphoria Scale; Cohen-Kettenis & van Goozen, 1997) 
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and body dissatisfaction (such as the Hamburg Body Drawing Scale; Becker et al., 2016), 
although useful, are limited. These measures have been developed with the binary gender 
system in mind (i.e., male or female) which is problematic in light of an increasing number of 
people identifying as non-binary or outside the gender binary (Beek et al., 2015; Clarke, 
Veale, Townsend, Frohard-Dourlent, & Saewyc, 2018; Richards et al., 2016, 2017); also, 
participants are asked to complete different versions depending on the gender they were 
assigned at birth. Measures developed to assess treatment outcomes within the transgender 
population therefore need to ensure they encapsulate people with non-binary gender identities 
and be gender neutral (i.e., applicable to all genders). A gender neutral measure also allows 
clinicians to assess outcomes using the same tool throughout the medical transition.  
In addition, for outcome evaluations to be meaningful, the measures employed must have 
been developed for, and validated with, the population in question (Dawson et al., 2010).  
 
Currently, mental health and quality of life measures that are used to assess patient outcomes 
at transgender health services have often been developed for use with other specific (and 
dissimilar) populations (e.g., Eating Disorder Inventory-2; Garner, 1991) or the general 
population (e.g., Hospital Anxiety and Depression Scale; Zigmond & Snaith, 1983). 
Therefore, these measures are unlikely to be specific enough (i.e., unlikely to ask about 
mental health problems in relation to gender distress) to be used with the transgender 
population for meaningful evaluations. Due to the lack of a suitable, validated mental health 
and quality of life measure, transgender health services usually invite patients to complete a 
series of measures that assess different constructs relating to mental health and quality of life 
to ensure evaluations are comprehensive. Research has found respondent burden to be great 
when patients are asked to complete multiple questionnaires, especially when these 
questionnaires assess similar constructs (Rolstad, Adler, & Ryden, 2011; Turner et al., 2007). 
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Respondent burden can affect the quality of data gathered and may reduce response rates 
(Diehr, Chen, Patrick, Feng, & Yasui, 2005; Snyder et al., 2007). In light of this, treatment 
evaluations collected at transgender health services may be of a poor quality as they might 
have been affected by respondent burden.  
 
Aims 
The objective of this study was to develop a self-report tool that was capable of assessing the 
outcomes of transgender health services. Patients are referred to transgender health services 
as a consequence of experiencing gender incongruence and therefore in the short-term the 
main aim of the tool was to assess levels of gender distress, gender congruence, and 
associated mental well-being. It was also expected that the tool would be able to assess long-
term outcomes by measuring levels of life satisfaction and psychological well-being. Such a 
tool is imperative to ensure evaluations are mapped onto the most important aims of gender 
affirming medical treatment and to allow meaningful and efficient evaluations to take place at 
transgender health services. The tool that was developed in the current study has been named 
the Gender Congruence and Life Satisfaction Scale (GCLS). Details of the development of 
the GCLS will be provided in the methods section. Once the tool had been developed, the 
first aim of this study was to explore the factor structure of the GCLS. The second aim was to 
explore the convergent and discriminant validity of the GCLS (types of construct validity). 
The final aim was to determine whether the GCLS can distinguish between subgroups (i.e., 
transgender and cisgender people) and be sensitive to changes in gender distress, gender 
incongruence, associated mental well-being, and life satisfaction throughout the treatment 
process (known-groups validity; a further type of construct validity). The final aim therefore 
also provides an opportunity to pilot the GCLS with transgender people and provide subscale 
norms.  
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Method 
Participants and recruitment 
Two different groups of participants were involved in this study: transgender people and 
cisgender (non-trans) people. Part of the study sample comprised transgender people who 
were invited to take part from a national transgender health service within the UK. This is a 
National Health Service (NHS) funded center, which offers assessment and treatment to 
transgender people who are pursuing, or are considering, medical transition. The center is one 
of the larger transgender healthcare services in Europe and receives around 1000 referrals a 
year from England and Wales. This service accepts referrals from people aged 17 and over. 
Clinicians at the service informed participants of the existence of the study and provided 
them with the information sheet and details about how to participate.  
 
Some transgender people and all of the cisgender participants were recruited through the 
community via snowball sampling. All transgender and cisgender people recruited through 
the community were required to be aged 18 or over. This was achieved by sharing an online 
link to the study with transgender support organizations (for transgender people only), via 
social media websites, and by email. The content of this advertisement was the same for 
transgender and cisgender people recruited through the community. Participants who took 
part in the online survey were then asked to pass the link on to others in their network.  
 
Recruitment took place over four months in 2016. A total of 458 transgender participants 
were invited. However, from this sample, seven people were removed as they either had 
provided no information about their gender assigned at birth and gender identity (n = 3) or 
had not indicated whether or not their gender assigned at birth and gender identity were the 
same (n = 4). Thus, the final sample consisted of 451 transgender people. In addition, a total 
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of 375 cisgender participants were invited. Of these participants, 37 were removed as they 
reported a gender identity that was different from the gender they were assigned at birth. The 
final cisgender sample consisted of 338 participants. The final sample size therefore included 
789 participants (338 identified as cisgender [42.8 %] and 451 as transgender [57.2 %]). 
 
Procedure 
After participants had read through the information sheet and decided whether or not they 
would like to take part, they were invited to complete the first iteration of the newly 
developed tool (GCLS). Participants recruited from the transgender health service were either 
asked to complete a paper questionnaire pack in their own time and return this to the service 
in a pre-paid envelope or complete the online survey. Community participants were asked to 
complete the survey online. No paper alternative was offered. Informed consent was obtained 
from all participants prior to taking part in the study. 
 
The study was approved by an NHS research ethics committee and by the Research and 
Development Department of Nottinghamshire Healthcare NHS Foundation Trust 
(16/EM/0183) in line with Health Research Authority guidance (HRA, 2013), as well as 
Loughborough University Research Ethics Committee. 
 
Development of the Gender Congruence and Life Satisfaction Scale 
Several processes were undertaken to complete the development of the GCLS. First, 
systematic reviews of the available literature on treatment outcomes, including body 
dissatisfaction (see Jones et al., 2016) and mental health were conducted (see Dhejne et al., 
2016). This was followed by a review of existing body dissatisfaction measures that are 
currently used to assess patient outcomes at transgender health services (Jones et al., 2016). 
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Next, in-depth interviews with 14 transgender people attending a national transgender health 
service in the UK were undertaken as part of a larger study (Jones, Arcelus, Bouman, & 
Haycraft, 2017). These interviews highlighted how distress and dissatisfaction with gender, 
associated mental well-being, and life satisfaction improved over the treatment process. The 
study provided valuable information regarding the most important objectives of transgender 
health services from the patients’ point of view. Following this, several discussions and focus 
groups took place with clinicians from different transgender health services in the UK, 
Sweden and Belgium. All of the outlined processes and studies mentioned above informed 
the first draft of the GCLS. The items within this first draft were developed as a result of the 
authors reviewing other self-report measures relating to gender incongruence, gender distress, 
mental well-being (including body dissatisfaction), and life satisfaction used with the 
transgender and cisgender population. This promoted a discussion among the research team 
about some of the limitations of these measures (e.g., not transgender specific, developed 
within the binary gender system). Some of the limitations were identified through earlier 
phases of development (i.e., the review of existing measure used to assess body 
dissatisfaction). The team then worked together to develop a list of items while taking into 
consideration some of the limitations identified in the previous phase. To be a valid item it 
had to: 1) be related to gender incongruence, gender distress, mental well-being or life 
satisfaction; 2) assess this construct in relation to gender incongruence and/or gender distress 
(e.g., I have felt extremely distressed when looking at my genitals); 3) be gender neutral. This 
process resulted in 85 items being developed.  
 
The first draft of the GCLS was then discussed with the Nottingham Centre for Transgender 
Health Service User Research Advisory Group (SURAG). This group consisted of 21 people, 
who were attending, or had attended the service and agreed to provide feedback for research 
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projects taking place at the service. This consultation resulted in a revised draft of the GCLS. 
The authors also worked in consultation with transgender people in the community, who were 
recruited through charities and support organizations for transgender and LGBT people 
within the UK. This included asking people to comment on the tool and the items that 
comprised it. Feedback was collected which allowed the development of the next draft of the 
scale, which was shared with several clinicians and academics in the field, including clinical 
academics from outside the UK (Sweden and Belgium). Following feedback, several drafts 
were developed which were discussed with the above groups until a tool that satisfied 
everyone was created.  This process resulted in a tool with 42 items initially being created. 
 
Measures 
Socio-demographic questions: Information about participants’ age, their gender assigned at 
birth and gender identity was collected. Participants were invited to provide information (if 
applicable) about their gender transition, including the amount of time they spend living in 
their experienced gender in their daily lives (less than 50 %, more than 50 %, or 100 % of the 
time). They were also asked whether they were using cross-sex hormones and/or blockers (if 
relevant) and whether they had undergone any gender affirming surgery (“Yes” or “No” 
response style). On the online survey, these questions were only visible to individuals who 
indicated incongruence between their birth and experienced gender (i.e., these questions were 
not visible to cisgender participants). 
 
Gender Congruence and Life Satisfaction Scale (GCLS; Jones, Bouman, Haycraft, & 
Arcelus, 2018; see Appendix): This 38-item scale aims to assess change and measure 
improvements in gender (in)congruence, related mental well-being, and life satisfaction 
throughout the process of undergoing gender affirming medical interventions. The scale is 
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independent of gender assigned at birth and was developed to be relevant to people who 
identify as male, female, as well as those who identify outside the binary gender system (e.g., 
non-binary identities). The GCLS asked respondents to think about how they have felt over 
the last 6 months and to rate their responses on a 5-point Likert scale (always = 1; never = 5). 
The 6 month time frame was selected to reflect the time transgender people have to of 
experienced gender incongruence and distress for to receive an official diagnosis of Gender 
Dysphoria as per the Diagnostic and Statistical Manual of Mental Disorders (DSM), fifth 
edition (American Psychiatric Association (APA), 2013). Although the GCLS is not a 
diagnostic tool, this time frame is felt to be important within the field of transgender health. 
Mean scores were calculated for each subscale. In the final (38 item) version of the scale, 11 
items were reverse coded (i.e., never = 1; always = 5). A higher score indicates a greater 
gender congruence, greater gender-related well-being, and greater life satisfaction. In 
contrast, a lower score indicates lower gender congruence, poorer gender-related well-being, 
and poorer general life satisfaction. 
 
Hamburg Body Drawing Scale (HBDS; Becker et al., 2016): This scale was originally 
developed by Appelt and Strauss (1988) for use with individuals with different forms of 
psychoendocrinological disorders and assesses satisfaction with 33 different body parts. 
Becker et al. (2016) recently validated the scale with the transgender population and adapted 
it to include male and female specific subscales. There is also an item that assesses overall 
satisfaction with appearance. This was the only item used in the current study and the reason 
for including it was to assess the convergent validity of the GCLS (i.e., to determine whether 
two measures that theoretically should be related, are related). The male and female subscales 
were not used within the current study as they were thought not appropriate to use with non-
binary identifying people. Participants were asked to rate their responses on a 5-point Likert 
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scale (1 = very dissatisfied; 5 = very satisfied) and therefore a higher score indicates a higher 
level of body satisfaction. Becker et al. (2016) found the HBDS subscales to have good 
reliability in a transgender population (α = .62-.91). As it was not possible to conduct 
reliability analysis with just one item, this was not calculated in the current study.  
 
Transgender Congruence Scale (TCS; Kozee, Tylka, & Bauerband, 2012): This 
measure has 12 questions, of which nine correspond with “appearance congruence” (e.g., I do 
not feel that my appearance reflects my gender identity; I am generally comfortable with how 
others perceive my gender identity when they look at me) and three relating to “gender 
identity acceptance” (e.g., I am not proud of my gender identity). Mean scores were 
calculated for each subscale. A global score can also be calculated by finding the mean of all 
responses. In the current study, only the 9-item appearance congruence subscale was used to 
assess convergent validity. Responses were rated on a 5-point scale from 1= strongly disagree 
to 5= strongly agree. A higher score indicates a higher level of transgender congruence. This 
measure has been found to have good reliability (α = .93; Kozee et al., 2012) and in the 
current sample, the appearance congruence subscale had excellent reliability (α = .96).  
 
World Health Organization Quality of Life-BREF (WHOQOL-BREF; Harper, 1998): 
The WHOQOL-BREF has 26 items which measures four domains: psychological, physical, 
relationships, and environment. There are also two items which are assessed separately, that 
ask about overall quality of life and overall health. In the current study the psychological and 
relationships subscales were used as well as the item that assessed overall quality of life, so 
as to assess convergent validity. The questions were rated on a 5-point Likert scale (1 = very 
dissatisfied; 5 = very satisfied) and a higher score indicates a higher quality of life. The 
subscale scores were calculated using the mean and then multiplied by four. This is to make 
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the scores from the WHOQOL-BREF comparable to the WHOQOL-100 (Harper, 1998), 
which is the longer original questionnaire. The WHOQOL-BREF has been found to have 
good to excellent reliability and validity in the general population and in clinical populations 
(e.g., rehabilitation, primary care, mental health) across 23 countries (Skevington, Lofty, & 
O’Connell, 2004). In this study, the psychological (α = .89) and relationships (α = .76) 
subscales had very good reliability.  
 
Internet Gaming Disorder Scale-Short Form (IGDS; Pontes & Griffiths, 2015): This 
measure is a brief 9-item questionnaire that assesses internet gaming behavior (e.g., Do you 
systematically fail when trying to control or cease your gaming activity?). Participants were 
asked to rate their responses on a 5-point Likert scale (1 = never; 5 = very often). Scores 
range from 9-45 and were calculated by summing all responses. A higher score indicates 
more problematic gaming behavior. The measure has good reliability (α = .87) (Pontes & 
Griffiths, 2015) and in this study had excellent reliability (α = .92). This measure was 
included within the current study to assess discriminant validity (i.e., to determine whether 
two measures were not related, as would theoretically be expected).  
 
Statistical Analysis 
For the first aim of the study, principal component analysis was conducted with data from the 
transgender participants only to determine the factor structure of GCLS. For factor analysis, 
Comrey and Lee (1992) suggested that 300 participants is a good sample size and therefore 
the number of transgender participants (n = 451) is considered adequate. For the second aim, 
convergent and discriminant validity testing was conducted. To assess convergent and 
discriminant validity, one-tailed Spearman’s Rho correlations (as the data were not normally 
distributed) were conducted between the GCLS and the WHOQOL, HBDS, TCS and IGDS 
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with the transgender participants only (n = 451). As multiple comparisons were conducted, 
Bonferroni corrections were used (.05 ÷ 13 = .004). For the final aim, known-groups validity 
testing (another form of construct validity) was conducted. This analysis determines whether 
known-groups within the dataset, in this circumstance transgender people at different stages 
of their transition (i.e., cross-sex hormones versus no cross-sex hormones) and cisgender 
people score in a theoretically expected way on the GCLS (e.g., transgender people score 
lower than cisgender people indicating a poorer outcome). Norm values were also generated 
for the GCLS subscales, global scale and clusters explored among the different groups. One-
tailed Mann-Whitney U tests were conducted for this aim as the data were not normally 
distributed. The significance level was set at p < .05. 
 
Results 
Descriptive statistics relating to the gender identities of the transgender people are displayed 
in Table 1. The mean age of the transgender participants was 36.94 (SD = 15.46) and ranged 
from 17 to 77 years. Of the 451 transgender people, 189 (41.9 %) had not undergone any 
gender affirming medical intervention, 145 (32.2 %) had taken cross-sex hormone treatment 
only, 22 (4.9%) had taken cross-sex hormones and undergone mastectomy only, 92 (20.4 %) 
had taken cross-sex hormone treatment and undergone genital surgery (+ / - mastectomy) and 
3 (.7) had undergone genital surgery but were not taking cross-sex hormone treatment. In the 
cisgender sample, 84 (24.9 %) were male and 254 female (75.1 %). The mean age of the 
cisgender sample was 36.52 (SD = 12.23) and ranged from 19 to 70 years.  
 
INSERT TABLE 1 ABOUT HERE 
 
Aim 1: Factor structure of GCLS 
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Preliminary analyses 
To explore the factor structure of the GCLS, principal component analysis was conducted. It 
was expected that the items on the GCLS would be related and so therefore oblique (direct 
oblimin criterion) rotation was employed. As preliminary analysis, multicollinearity and 
singularity were assessed. The determinant was above .00001 and therefore multicollinearity 
and singularity were not a cause for concern. Bartlett’s Test of Sphericity was also significant 
(p < .001) suggesting that correlations between variables were significantly different from 
zero and therefore it was concluded that variables were adequately related to find clusters 
within the dataset.  
 
Exploratory factor analysis and item elimination 
Analysis to determine the number of factors to retain was conducted. Kaiser (1960) suggested 
that factors with an eigenvalue greater than one should be retained. Kaiser’s criteria is seen to 
be accurate when the sample size exceeds 250 (current sample n = 451) and the average 
communality is equal or greater than .6 (.67 in the current study; Field, 2013). Seven factors 
with an eigenvalue greater than one were identified and explained 67.30 % of the total 
variance. In contrast, the scree plot suggested five factors should be extracted (Cattell, 1966). 
Courtney and Gordon (2013) recommended that other statistical techniques (other than the 
eigenvalue and scree plot) should also be used to establish the number of factors to extract. 
Additional analysis was therefore conducted and Ruscio and Roche’s (2012) comparative 
data technique suggested seven factors should be retained, as did Velicer’s (1976) minimum 
average partial (MAP) test. Courtney and Gordon (2013) found Ruscio and Roche’s (2012) 
comparative data technique to have 87.14 % accuracy and Velicer’s (1976) MAP test to have 
59.6 % accuracy in determining the number of factors to retain. Based on these analyses, 
seven factors were explored.  
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Item retention and elimination were subsequently considered in accordance with several 
criteria. Stevens (2002) suggested that for a sample size greater than 300 (current sample n = 
451), item loadings should be greater than .30 to be retained within a factor. All item loadings 
in the current study were above .30 and therefore all 42 items were retained at this stage. 
Next, the interpretability of items was explored by an expert panel working in the area of 
transgender health (n = 8) and any items which were not found to theoretically or 
conceptually fit within the factor they had been placed were excluded. Based on this review, 
items 21, 27, 28 and 30 were excluded. When items cross-loaded simultaneously onto two (or 
more) factors with a difference of less than .10, the face validity of the item was considered. 
This applied to items 10, 19, 26 and 41. Items 10 (-.39), 26 (.42) and 41 (-.39) and were felt 
to conceptually fit better within the factors that they loaded highest with and therefore were 
retained within these factors. It was also felt that item 19 did not conceptually fit within 
factor 1 (the factor which the item loaded the highest, .41), however it also loaded highly 
onto factor 3 (.39) and was felt to conceptually fit better within this factor (in comparison to 
factor 1). Therefore, item 19 was retained within factor 3. In total, four items were removed 
which resulted in the revised version of the GCLS comprising 38 items. 
 
Analysis of the remaining 38 items  
The remaining 38 items were then subjected to a second principle components analysis with 
oblique (direct oblimin criterion) rotation. Seven factors had an eigenvalue greater than one, 
which explained a large proportion of the overall variance (68.01 %; see Table 2). All item 
loadings were greater than .30 and all items conceptually and theoretically fitted within the 
factor that they had been placed. The only exception to this rule was item 19, which loaded 
highly onto factor 1 and factor 3 and was moved from factor 1 to 3 as it was felt to better 
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conceptually fit within factor 3. Therefore 38 items were retained to comprise the final 
version of the GCLS.  
 
The first factor (10 items) included items that related to psychological functioning associated 
with gender (in)congruence and was labelled “psychological functioning”. The second factor 
(6 items) included questions that pertained to distress and incongruence relating to the 
genitals and therefore was named “genitalia”. The third factor (4 items) included questions 
that asked about the degree to which participants were satisfied with how others perceived 
their gender role and therefore these items were categorized as “social gender role 
recognition”. The fourth factor (4 items) asked participants about satisfaction with their 
physical and emotional relationships and therefore was named “physical and emotional 
intimacy”. The fifth factor (4 items) was labelled “chest” as it included questions that asked 
about distress and incongruence with the chest. The sixth factor (3 items) included questions 
that were related to distress and incongruence experienced in relation to non-genital 
secondary sex characteristics (e.g., hair, voice) and therefore these questions were 
categorized as “other secondary sex characteristics”. The seventh factor (7 items) included 
questions that assessed general life satisfaction (not related to gender incongruence) and 
therefore was labelled “life satisfaction”. From reviewing these subscales, they appeared to 
conceptually cluster into two overarching themes; one that directly assessed the degree of 
gender congruence (factors 2, 3, 5 and 6) and another that assessed gender-related mental 
well-being and general life satisfaction (factors 1, 4 and 7). The clusters can be used by 
calculating the mean scores for the involved items.  
 
Internal consistency 
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Internal consistency for each of the GCLS subscales and the global score (comprising all 38 
items) were calculated. All seven subscales were found to have good (> .7) internal 
consistency (Nunnally, 1978; see Table 2) and the internal consistency for the global score 
was excellent (α = .95). 
INSERT TABLE 2 ABOUT HERE 
 
Aim 2: Convergent and discriminant validity  
In order to test the construct validity of the GCLS (i.e., the degree to which the GCLS 
measures what it claims to), Spearman’s Rho correlations were conducted between the GCLS 
and the WHOQOL, HBDS, TCS and IGDS with the transgender participants only (n = 451). 
Construct validity comprises convergent and discriminant validity. For the GCLS to show 
convergent validity (i.e., to determine whether two measures that theoretically should be 
related, are related), it would be expected to have a moderate to high correlation with the 
WHOQOL, HBDS and TCS (Evans, 1996). As might be expected, the GCLS physical and 
emotional intimacy subscale had a strong significant association with the WHOQOL 
relationships subscale, as did the GCLS psychological subscale and the WHOQOL 
psychological subscale. Additionally, the GCLS chest, GCLS genitalia and GCLS other 
secondary sex characteristics subscales had a moderate to strong association with the HBDS 
overall satisfaction scale. The GCLS social gender role recognition, GCLS other secondary 
sex characteristics, GCLS chest and GCLS genitalia subscales also all had a moderate to 
strong significant association with the TCS appearance congruence subscale. The strongest 
significant association was found between the GCLS life satisfaction and the WHOQOL 
overall quality of life subscale. These results confirm the convergent validity of the GCLS 
(see Table 3).  
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Next, correlations were run to determine discriminant validity; that is, to test whether the 
GCLS and IGDS are unrelated (i.e., a weak correlation) as would theoretically be expected. 
Table 4 shows that the GCLS subscales and the IGDS were unrelated as the two measures are 
weakly associated with one another (e.g., below r = .39; Evans, 1996). This suggests that the 
GCLS has discriminant validity. It is likely that some of these correlations will have reached 
statistical significance due to the large sample size of the current study (Field, 2013).  
 
INSERT TABLE 3 ABOUT HERE 
INSERT TABLE 4 ABOUT HERE 
 
Aim 3: Known-groups’ validity  
To determine whether the GCLS is capable of distinguishing between subgroups (e.g., 
cisgender people and transgender people who have had no gender affirming medical 
intervention) and to determine whether groups score in a theoretically expected way (e.g., 
people who have undergone gender affirming medical treatments will be expected to score 
higher than people who have not undergone gender affirming medical treatments on all 
subscales of the GCLS) known groups validity (a further type of construct validity) was 
conducted using Mann-Whitney U tests (Hattie & Cooksey, 1984). Known-groups testing has 
previously been used to assess the construct validity of self-report measures (e.g., Alvarenga, 
Scagliusi, & Philippi, 2010). In the current study, some of these analyses were conducted 
between known-groups within the transgender sample, and some between transgender and 
cisgender participants. These analyses are not exhaustive but provide subscale and cluster 
norms for the different groups explored.  
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Initially, responses on the GCLS for transgender participants who had not undergone any 
gender affirming medical treatment (n = 189) and cisgender people (n = 338) were compared. 
It was found that the cisgender participants scored significantly higher (indicating a more 
positive outcome) on all GCLS subscales and the global scale than transgender people who 
had not undergone any gender affirming medical interventions (see Table 5). Responses 
between the two groups were also compared on the GCLS clusters previously identified. It 
was found that cisgender people scored significantly higher (indicative of a more positive 
outcome) than transgender people who were yet to undergo gender affirming medical 
interventions on the gender congruence cluster and the gender-related mental well-being and 
life satisfaction cluster (see Table 5). All effect sizes for the comparative analysis were large 
(Field, 2009). 
 
INSERT TABLE 5 ABOUT HERE 
 
Next, a Mann-Whitney U test was conducted to compare responses on the GCLS between 
transgender males who had not undergone any gender affirming medical intervention (n = 46) 
and transgender males who had taken cross-sex hormone treatment and undergone chest 
reconstructive (but not genital) surgery (n = 17). Within the UK (which is where these data 
were collected) chest reconstructive surgery is funded by the NHS. However, breast 
augmentation surgery is not funded, hence these analyses were only conducted in relation to 
transgender males. The analyses demonstrated that transgender males who had taken cross-
sex hormones and undergone chest reconstructive scored significantly higher (more positive 
outcome) on the psychological functioning, social gender role recognition, chest, other 
secondary sex characteristics, and life satisfaction subscales of the GCLS as well as the 
global scale, than transgender males who had not undergone any gender affirming medial 
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intervention (see Table 6). No significant differences were found between the two groups on 
the genitalia and physical and emotional intimacy subscales of the GCLS. The two groups 
were also compared on the GCLS clusters and it was found that transgender males who had 
taken cross-sex hormones and undergone chest reconstructive surgery scored significantly 
higher (more positive outcome) on the gender congruence cluster and the gender-related 
mental well-being and life satisfaction cluster than transgender males who had not undergone 
any gender affirming medical interventions (see Table 6). Effect sizes for the comparative 
analysis were large (social gender role recognition; chest; other secondary sex characteristics; 
global scale; and cluster one), medium (psychological functioning; cluster two) and small 
(genitalia; physical and emotional intimacy; life satisfaction) (Field, 2009). 
 
INSERT TABLE 6 ABOUT HERE 
 
Finally, a Mann-Whitney U test was conducted between responses on the GCLS for 
transgender participants who were yet to undergo any gender affirming medical intervention 
(n = 189) and people who had taken cross-sex hormone treatment and undergone genital 
surgery (+ / - chest reconstructive surgery; n = 92).  People who had taken cross-sex hormone 
treatment and undergone genital surgery (+ / - chest reconstructive surgery) scored 
significantly higher (more positive outcome) on all GCLS subscales and the global scale 
compared to people who had not undergone any gender affirming medical interventions (see 
Table 7). The groups were also compared on the two clusters and it was found that 
transgender people who had taken cross-sex hormone treatment and undergone genital 
surgery (+ / - chest reconstructive surgery) scored significantly higher (more positive 
outcome) on the gender congruence cluster and the gender-related mental well-being and life 
satisfaction cluster than people who had not undergone any gender affirming medical 
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intervention (see Table 7).  Effect sizes for the comparative analysis were large (social gender 
role recognition; chest; cluster one), medium (psychological functioning; other secondary sex 
characteristics; life satisfaction; global scale; cluster two) and small (genitalia; physical and 
emotional intimacy) (Field, 2009). 
 
INSERT TABLE 7 ABOUT HERE 
 
Summary of analysis  
Factor analysis on items of the GCLS supported a 7-factor solution with 38 items retained in 
total. The seven subscales are: psychological functioning; genitalia; social gender role 
recognition; physical and emotional intimacy; chest; other secondary sex characteristics; and 
life satisfaction. The subscales can be categorized into two clusters; 1) gender congruence 
(genitalia, chest, other secondary sex characteristics and social gender role recognition), and 
2) gender-related mental well-being and general life satisfaction (physical and emotional 
intimacy, psychological functioning and life satisfaction). A higher score indicates a greater 
gender congruence, greater gender-related well-being, and greater life satisfaction. The 
GCLS subscales and the global scale have undergone vigorous testing and have demonstrated 
good reliability and validity. Subscale, global scale and cluster norms for transgender people 
at different stages of medical transition, as well as cisgender people have been generated. The 
known groups’ analysis also demonstrated that the measure is capable of discriminating 
between groups of interest (e.g., people who have and have not undergone gender affirming 
medical interventions) and highlights how gender incongruence, gender-related mental well-
being and general life satisfaction improve over the course of the medical transition. It can 
therefore be concluded that the GCLS is a suitable tool to use with the transgender population 
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to measure gender congruence and life satisfaction, and - in particular - improvements in 
these that are likely to occur during the treatment process. 
 
Discussion 
The main aim of this study was to develop and evaluate a new transgender health outcome 
measure: the Gender Congruence and Life Satisfaction Scale (GCLS) which is capable of 
measuring changes in gender congruence and life satisfaction over the course of gender 
affirming medical interventions. The GCLS is the first transgender health outcome measure 
that can be used independently of gender assigned at birth and gender identity. This study 
confirmed that the GCLS is a valid and reliable measure to use with the transgender 
population and is capable of producing high quality outcome data for clinical and research 
purposes. 
 
Clinical utility of the GCLS 
Having a brief, self-report questionnaire that is capable of assessing transgender health 
outcomes is important in order to measure the quality of care that is offered at transgender 
health services (Dawson et al., 2010), to enable transgender patients to be followed-up over 
time (both before and after gender affirming medical interventions), and to determine what 
transgender healthcare needs people require. The latter may help with financial planning and 
future workforce and service development in the field of transgender healthcare.  
The GCLS was developed in collaboration with the transgender population and healthcare 
professionals working in the field of transgender health. This has ensured that the GCLS is 
meaningful and relevant for use as an outcome measure for people attending transgender 
health services (T’Sjoen, Motmans, Arcelus & Bouman, 2017). Factor analysis suggested the 
retention of 38 items, which comprised seven subscales (psychological functioning, genitalia, 
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social gender role recognition, physical and emotional intimacy, chest, other secondary sex 
characteristics, and life satisfaction) that were clustered into two themes: 1) gender 
congruence and 2) gender-related mental well-being and general life satisfaction. The two 
clusters have clinical relevance and applicability as some transgender people may or may not 
experience mental health problems in association with the distress and unhappiness they 
experience with their gender (e.g., Dhejne et al., 2016). The existence of two separate clusters 
therefore allows these factors to be considered separately. In addition, the outcome of 
transgender health services can be divided into outcomes related to the symptomatology that 
the individual presents to the service with (i.e., gender incongruence and gender dysphoria) 
and outcomes that relate to psychological well-being (life satisfaction, and mental health). 
Being able to review the scores on these two clusters may allow clinicians and healthcare 
professionals to deliver a patient-centered service. The delivery of patient-centered 
interventions is crucial to improve patient outcomes (e.g., Lauver et al., 2002). The mean 
scores given for each subscale, the global score and cluster of the GCLS for transgender 
people at different stages of medical transition within the current study can be used as norms. 
Subscale and cluster norms have also been provided for cisgender people; a sample that may 
provide a useful reference point for both future clinical and research purposes.  
 
Research utility of the GCLS 
It is expected that the GCLS may not only be a useful clinical tool, but may also aid research 
in the field of transgender health. As part of the validation process, the GCLS has already 
demonstrated that it can distinguish between subgroups of transgender individuals who are at 
different stages of medical transition, which makes it a suitable research tool. The current 
study found that transgender people who had not undergone any gender affirming medical 
interventions reported worse outcomes on all GCLS subscales, the global scale and two 
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clusters than both cisgender people and transgender people who had taken cross-sex hormone 
treatment and undergone genital surgery (+ / - chest reconstructive surgery). These findings 
support previous research that has shown patients to report less distress with their gender, 
lower levels of body dissatisfaction, better mental well-being, and greater life satisfaction 
after they had undergone gender affirming surgery (e.g., Dhejne et al., 2016; Jones et al., 
2016; Marinkovic and Newfield, 2017; Marshall et al., 2015; Murad et al., 2010; van de Grift 
et al., 2018; Witcomb et al., 2018). 
 
This study also found that transgender males who had not undergone any gender affirming 
medical intervention reported worse outcomes on the chest, other secondary sex 
characteristics, social gender role recognition, psychological functioning, and life satisfaction 
subscales of the GCLS, as well as the global scale and the two clusters, than transgender 
males who had taken cross-sex hormone treatment and undergone chest reconstructive 
surgery. There was no significant difference between the two groups on the genitalia and 
physical and emotional intimacy subscales of the GCLS. This finding supports previous 
research, which has found dissatisfaction and distress with the genitalia to be increasingly 
prevalent post-chest reconstructive surgery in treatment-seeking transgender men (van de 
Grift et al., 2016). Research with cisgender populations has found body dissatisfaction 
(Woertman & van den Brink, 2012), as well as specific genital dissatisfaction (Schick, 
Calabrese, Rima, & Zucker, 2010), to affect sexual satisfaction and therefore the high levels 
of dissatisfaction and distress experienced in relation to the genitalia in transgender men in 
the current study (pre-genital surgery) is likely to impact on their physical relationships.   
The analysis we conducted with known-groups demonstrates the sensitivity of the GCLS and 
its ability to distinguish between outcomes at different stages of medical transition (e.g., chest 
distress dissipates post-chest reconstructive surgery). Having a validated tool that is capable 
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of having this level of sensitivity may be extremely useful in advancing research in 
transgender health. For instance, when the length of time a person has been on cross-sex 
hormone treatment is known, longitudinal research may be able to identify a time frame in 
which long-term outcomes, such as psychological functioning and life satisfaction, improve. 
Establishing this in different subgroups (e.g., non-binary identifying people) is also 
important. The GCLS has been developed independent of gender assigned at birth and gender 
identity and therefore may also be an appropriate measure to use with non-binary identifying 
people. Research with this population is in its infancy, but suggests poorer mental health than 
binary transgender people (Rimes, Goodship, Ussher, Baker, & West, 2017; Scottish Trans 
Alliance, 2015; Thorne, Witcomb, Nieder, Nixon, & Arcelus, 2018; Warren, Smalley, & 
Barefoot, 2016). Some of the subscales from the GCLS may also be used to advance 
knowledge concerning factors that predict good outcomes in transgender people, for example, 
factors that predict life satisfaction. Establishing factors that predict a good outcome among 
non-binary identifying people is also essential as the factors are likely to differ to what is seen 
among transgender people who identify within the binary gender system.  
 
The GCLS is the first transgender health outcome measure to be developed and validated 
with the transgender population and is capable of assessing important treatment outcomes for 
treatment seeking binary and non-binary identifying people. However, there are some 
limitations to be considered. First, the GCLS was only validated in an English speaking adult 
population. Future research should focus on validating the GCLS in other languages and 
other age groups (e.g., children and adolescents). Second, although gender incongruence, 
related mental well-being, and life satisfaction were all found to improve over the course of 
gender affirming medical interventions in the current study, it must be considered that these 
conclusions were based on cross-sectional data and test re-test reliability was not established. 
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In addition to this, data were not collected in relation to whether or not participants were 
accessing transgender health services (i.e., were treatment seeking) or the length of time on 
cross-sex hormone treatment. To further explore the short and long-term outcomes of gender 
affirming medical interventions, longitudinal research that uses the GCLS in treatment 
seeking transgender people needs to be conducted. The gender of the cisgender participants 
within this study was also skewed (i.e., the majority were cisgender women). Future research 
should look to employ the GCLS with a larger sample of cisgender males to compare scores 
with transgender males. Contrary to expectations, some subscales of the GCLS significantly 
correlated with the IGDS. This is likely to be due to the large sample size in the current study 
(Field, 2013). This finding may warrant further research into gaming behavior of transgender 
people.  
 
In conclusion, the findings from this study suggest that the GCLS is a suitable and robust 
measure to assess treatment outcomes in relation to gender congruence, related mental well-
being, and life satisfaction within the transgender population in both a clinical and research 
capacity. Having a measure that is capable of assessing these outcomes may allow for the 
quality of gender affirming interventions to be improved within transgender health services, 
and thus may improve the quality of life of transgender people and their families.  
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Appendices  
Gender Congruence and Life Satisfaction Scale (GCLS) 
Jones, Bouman, Haycraft and Arcelus 
 
 
Citation and tool use: The GCLS is freely available for use. Please contact the authors if you 
have any questions about the scale: 
Beth Jones: B.Jones@lboro.ac.uk  
Prof Jon Arcelus: Jon.Arcelus@nottingham.ac.uk 
 
If you would like to use the tool in a different language (i.e., translate it) then please contact 
the authors as they may already have it available in your language. This will avoid several 
versions of the tool being created in the same language. We hope you find this tool useful. 
 
Scoring instructions: Items are scored on a 5-point scale (always=1; never=5). Items with an 
asterisk (indicated below) need to be reverse scored (always=5, never=1). A higher score 
therefore indicates a more positive outcome (higher gender congruence, better gender-related 
mental well-being, and better general life satisfaction).  
 
To score item 26, if the participant indicates (by ticking the box) that they have had genital 
surgery, score their response as missing data. If they have not ticked the box, score their 
response as for the other GCLS items (always=1; never=5). 
 
To obtain subscale scores and the global score, calculate the mean score. The global score 
comprises all 38 items. The items that comprise each subscale are listed below: 
 
1. Genitalia: 14, 21, 25*, 26, 27 and 29 (6 items) 
2. Chest: 15, 18, 28 and 30* (4 items) 
3. Other secondary sex characteristics: 17, 23 and 24 (3 items) 
4. Social gender role recognition: 16*, 19, 20* and 22* (4 items) 
5. Physical and emotional intimacy: 3, 5, 32* and 33* (4 items) 
6. Psychological functioning: 1, 2, 4, 6, 7, 8, 9, 11, 12 and 13 (10 items) 
7. Life satisfaction: 10, 31*, 34*, 35, 36*, 37 and 38* (7 items) 
 
The subscales can also be grouped into two clusters. Cluster 1, gender congruence, comprises 
subscales 1-4, and cluster 2, gender related mental well-being and life satisfaction, 
comprises subscale 5-7. To obtain the cluster scores, calculate the mean of all the items in that 
cluster:  
 
Cluster 1 (gender congruence): 14, 15, 16*, 17, 18, 19, 20*, 21, 22*, 23, 24, 25*, 26, 27, 28, 
29, 30* 
Cluster 2 (gender-related mental well-being and general life satisfaction): 1, 2, 3, 4, 5, 6, 7, 8, 
9, 10, 11, 12, 13, 31*, 32*, 33*, 34*, 35, 36*, 37, 38* 
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Gender Congruence and Life Satisfaction Scale (GCLS) 
 
Below is a range of statements about how you might feel in relation to your gender, mental 
well-being, and life satisfaction. Please respond to each statement, thinking about how 
frequently you have felt like this in the past 6 months.  
Please rate each statement as: NEVER (N), RARELY (R), SOMETIMES (S), OFTEN (O) 
or ALWAYS (A).  
Please note that when talking about ‘gender identity’ we mean one’s internal sense of one’s 
self as a man, a woman, or some other gender. 
In the past 6 months, due to the distress about my gender  (i.e., the 
distress caused as the gender I was assigned at birth does not match 
with my gender identity):   
     
1. I have avoided social situations and/or social interactions N R S O A 
2. I have not gone to school/college/work 
 
N R S O A 
3. I have not been able to have emotional relationships with 
other people 
N R S O A 
4. I have suffered from anxiety 
 
N R S O A 
5. I have not been able to be physically intimate with other 
people 
N R S O A 
6. I have been unable to leave the house 
 
N R S O A 
7. I have found it difficult to make friends 
 
N R S O A 
8. I have thought about cutting or hurting my chest, genitals 
and/or surrounding areas 
N R S O A 
9. I have felt that life is meaningless   
 
N R S O A 
10. I have not enjoyed life 
 
N R S O A 
11. I have not engaged in leisure activities 
 
N R S O A 
12. I have suffered from low mood 
 
N R S O A 
13. I have thought about hurting myself or taking my own life 
 
N R S O A 
 
GCLS continues over… 
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Please rate each statement as: NEVER (N), RARELY (R), SOMETIMES (S), OFTEN (O) or 
ALWAYS (A). 
In the past 6 months:       
14. I have felt distressed when touching my genitals as they do 
not match my gender identity  
N R S O A 
15. I have felt so distressed about my chest that I have not been 
able to have a fulfilling life 
N R S O A 
16. I have felt comfortable with how others have perceived my 
gender 
N R S O A 
17. I have felt that my body hair conflicts with my gender 
identity, either because I have it and do not like it or because 
I would like to have it   
N R S O A 
18. I have felt like my chest does not match my gender identity N R S O A 
19. I have found it distressing that others do not address me 
according to my gender identity  
N R S O A 
20. I have felt satisfied with the pronouns that others use when 
talking about me 
N R S O A 
21. I have felt unhappy about my genitalia since they do not 
match my gender identity 
N R S O A 
22. I have felt comfortable with how other people perceive my 
gender based on my physical appearance 
N R S O A 
23. I have felt that my voice has affected the way other people 
have perceived my gender identity which has been distressing 
for me 
N R S O A 
24. I have felt that my facial hair conflicts with my gender 
identity, either because I have it and do not like it or because 
I would like to have it 
N R S O A 
25. I have felt that my genitals do match with my gender identity N R S O A 
26. I have felt that genital surgery will address the unhappiness I 
experience in relation to my gender  
□ Tick here if you have already had genital surgery 
(unless you feel you need more) 
N R S O A 
27. I have been unable to have a fulfilling life because of the 
distress relating to my genitalia  
N R S O A 
28. I have felt extremely distressed when looking at my chest 
 
N R S O A 
29. I have felt extremely distressed when looking at my genitals 
 
N R S O A 
30. I have felt satisfied with my chest 
 
N R S O A 
 
GCLS continues over… 
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Please rate each statement as: NEVER (N), RARELY (R), SOMETIMES (S), OFTEN (O) 
or ALWAYS (A). 
Next, we would like to know how satisfied you have been with your 
life for the last 6 months:  
     
31. I have felt satisfied at school/college/work 
 
N R S O A 
32. I have felt satisfied with my emotional relationship(s) 
 
N R S O A 
33. I have felt satisfied with my sex life 
 
N R S O A 
34. I have felt satisfied in my leisure activities and hobbies 
 
N R S O A 
35. I have not felt satisfied with my friends  
 
N R S O A 
36. I have felt satisfied with the support I have received from 
other significant people 
N R S O A 
37. I have not felt satisfied with my health 
 
N R S O A 
38. I have felt satisfied with life in general 
 
N R S O A 
 
 
 
